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Abstract  
Background: The aim of this systematic review and meta-analysis was to compare health-
related quality of life (HRQOL) outcomes between minimally invasive and open 
oesophagectomy for cancer at different postoperative time points 
Methods: A search of PubMed (MEDLINE), Web of Science, EMBASE, Scopus, CINAHL 
and Cochrane Library was performed, yielding 2853 titles. Nine studies comparing patients 
who underwent minimally invasive surgery (n=1161) with those who underwent open surgery 
(n=903) were included in the systematic review based on eligibility criteria. A random-effects 
meta-analysis was conducted based on eight studies that measured HRQOL scores using the 
EORTC QLQ-C30 and QLQ-OES18 questionnaires. Mean score differences (MSD) >10 were 
considered clinically relevant. Pooled effects of MSD with 95% confidence intervals (CI) 
were estimated to assess statistical significance.  
Results: Patients who underwent minimally invasive surgery had on average better scores for 
global quality of life (MSD 11.6, 95% CI 3.8 to 19.4), physical function (MSD 11.9, 95% CI 
3.9 to 19.8), fatigue (MSD -13.2, 95% CI -17.6 to -8.8), and pain (MSD -15.9, 95% CI -20.5 
to -11.2) than those who underwent open surgery at 3 months after surgery. At 6 and 12 
months after surgery, no significant differences remained. 
Conclusion: This meta-analysis indicates better average global quality of life, physical 
function, fatigue and pain 3 months following minimally invasive surgery compared to open 
surgery. No such differences remain at longer follow-up of 6 and 12 months. This knowledge 
can guide clinical decision-making and improve patient information.  
 
 
 
 
Introduction 
Oesophageal cancer is the 9
th
 most common cancer and the 6
th
 most common cause of cancer 
death worldwide.
1
 The mainstay curative option for most patients with locally advanced 
cancer is oesophagectomy, often preceded by neoadjuvant therapy.
2
 Surgical resection is 
associated with a high rate of post-operative morbidity, and health-related quality of life 
(HRQOL) can deteriorate substantially following such radical surgery.
3
 In recent years 
minimally invasive techniques using a combination of thoracoscopic and/or laparoscopic 
approaches have been used increasingly, with the primary aims of reducing surgical trauma, 
minimising complications and improving postoperative recovery.
4
 In addition to a few cohort 
studies, one randomized clinical trial has indicated that specific components of short-term 
HRQOL may be improved through utilization of a minimally invasive approach to 
esophagectomy.
5
 However, great variability exists regarding which HRQOL outcomes have 
been assessed and the time period after surgery that these were evaluated.
6, 7
 There is 
presently no conclusive evidence as to whether HRQOL in general is improved following 
minimally invasive oesophagectomy compared to open surgery, if any specific HRQOL 
outcomes differ between these approaches and the length of time these persist following 
surgery.  
Therefore, the aim of this systematic review and meta-analysis was to clarify potential 
differences in postoperative HRQOL outcomes over time after minimally invasive compared 
to open oesophagectomy for oesophageal cancer. 
  
 
 
 
 
Methods 
This systematic review was conducted according to the PRISMA guidelines.
8
 An a priori 
established detailed study protocol was followed. 
 
Search strategy 
A comprehensive literature search was conducted in September 2016 using a keyword search 
on PubMed (MEDLINE), Web of Science, EMBASE, Scopus, CINAHL and Cochrane, from 
the inception of each database. The following search string was used: (mini-invasiv* OR 
minimally-invasive OR minimally invasive OR vats OR thoraco* OR laparo*) AND 
(esophag* OR oesophag* OR gastro-oesophag* OR gastroesophag*) AND (neoplas* OR 
tumo* OR cancer OR carcinoma OR adenocarcinoma) AND (Quality of life OR qol OR hqol 
OR hrqol).  
Study selection 
Studies considered for inclusion in the systematic review and meta-analysis had the following 
characteristics:  
1) Original studies. 
2) Written in English. 
3) Oesophageal cancer or high-grade dysplasia (HGD) were primary indications for 
oesophagectomy. 
4) HRQOL data were assessed using any well-validated HRQOL instrument or its derivative. 
5) HRQOL outcomes were measured both before and after the oesophagectomy. 
6) Post-operative HRQOL was compared between minimally invasive and open surgical 
procedures.  
The search identified 2853 titles. The titles and abstracts of these studies were evaluated. 
When the studies seemed to meet the eligibility criteria, or when information was insufficient 
 
 
 
 
to exclude them, the full articles were reviewed. The reference lists of the retrieved articles, 
PubMed “related articles” and articles dealing with the literature review were scanned for 
potential additional studies. After the search, one author (J.H.K.) performed the screening of 
all titles and abstracts. Studies were included according to the eligibility criteria above. After 
the initial screening, full text articles were obtained. Full-text articles were independently 
studied by two authors (J.H.K., and P.L). In the case of discrepancies, the studies were 
discussed based on the pre-determined eligibility criteria between the authors and resulted in a 
consensus decision. The workflow is summarized in Figure 1. 
 
Data extraction 
All data from eligible studies were independently extracted by two investigators (J.H.K., and 
S.X.) to maintain the integrity of the data. Gathered information included the name of first 
author, publication year, study period, design, population characteristics (age and sex), 
treatment, number of patients in the two surgery groups, HRQOL indicators used and 
HRQOL outcomes at baseline and different time points after surgery. First authors and 
corresponding authors in the eligible studies were contacted by email up to three times to 
obtain unreported data.  
 
Quality assessment  
Study quality and bias were assessed separately by two authors (J.H.K. and P.L.) using the 
Newcastle-Ottawa scale, as all but one of the included studies were cohort studies.
9
 The pre-
determined items for assessment of study quality and results were used to rank the studies. 
Discrepancies between assessors were settled upon discussion. Bias in individual studies was 
analysed qualitatively. 
 
 
 
 
 
Definition of exposure and outcome 
The study exposure was divided in two categories, namely minimally invasive 
oesophagectomy and open oesophagectomy. Minimally invasive oesophagectomy included 
hybrid approaches such as laparoscopic-assisted, hand video-assisted and thoracoscopic-
assisted, and totally minimally invasive (both laparoscopic and thoracoscopic) procedures. 
Open procedures included Ivor-Lewis- and left transthoracic thoraco-abdominal 
oesophagectomy (with intra-thoracic anastomosis), three-incision oesophagectomy (with neck 
anastomosis), and transhiatal oesophagectomy (with neck anastomosis).  
Outcome of interest was HRQOL, a multidimensional measure consisting of physical health, 
psychological health, functional status, social relationships, and personal beliefs.
10
 HRQOL 
can be classified as generic or disease-specific and measured using a variety of scales and 
indicators. The HRQOL questionnaires that were used in the included studies were the 
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 
C30 v3.0 core questionnaire (EORTC QLQ-C30) measuring cancer-related functions and 
symptoms,
11
 EORTC oesophageal cancer-specific HRQOL module (EORTC QLQ-OES18) 
assessing disease related symptoms and items,
12
  short-form health survey (SF-36) measuring 
general health,
13
 the Multi-Dimensional Fatigue Inventory (MFI-20) measuring different 
aspects of fatigue,
14
 a modified Katz Scale and a modified Lawton and Brody Scale 
measuring daily activities.
15
 The HRQOL questionnaires used in the studies were checked for 
validity in the native languages of the countries of origin specified in Table 1.  
 
Statistical analysis 
The statistical analyses were performed using RevMan version 5.3 (The Cochrane 
Collaboration, Oxford, UK) and STATA version 13.0 (StataCorp LP), according to the 
Cochrane guidelines for systematic reviews.
9
 Number of the patients in each treatment group 
 
 
 
 
was collected as reported in the individual studies. Standard deviations were calculated based 
on the standard error of the mean value and patient number at each time point for each of the 
two surgery groups. Missing data on standard deviations were imputed using the largest 
reported standard deviation for the outcome with the given surgical operation at a given time 
point.
9, 16
 This approach was used to obtain the most conservative effect estimate. Data 
available only in graphical format were extracted using the WebPlotDigitizer tool 
(http://arohatgi.info/WebPlotDigitizer). In one included study,
17
 two open oesophagectomy 
procedures were combined as suggested in the Cochrane Handbook.
9
 To evaluate potential 
bias due to imputation of standard deviations for two of the included studies, we performed a 
sensitivity analysis including only the studies that did not require any data to be imputed. 
Continuous variables were analysed using inverse variance according to the DerSimonian-
Laird method.
18
 To obtain estimates of the average treatment effects, a random effects model 
was used to estimate mean differences for continuous data across the studies.
19
 Mean score 
differences (MSD) and pooled effects with 95% confidence intervals (CI) were depicted on 
forest plots. Based on previous literature, the mean differences were considered clinically 
significant only if the pooled differences were at least 10 points, which correspond to at least 
a “moderate” change or difference for the patients.20, 21 Statistical heterogeneity of the studies 
was assessed in terms of the I
2
 statistic.
22
 An I
2
 statistic <25% indicated a minor 
inconsistency, and an I
2
 statistic >50% indicated a major inconsistency. As the random-effects 
meta-analysis calculates the average effect of a given treatment, 95% prediction intervals 
were calculated for each outcome at a given time point to estimate the range of true difference 
between the treatments in 95% of the population.
19, 23
 As the number of included studies was 
small, meta-regression could not be reliably performed.
24
 Thus, a sensitivity analysis was 
undertaken by removing one study at a time in the meta-analysis to estimate the influence of 
each study on the pooled estimate of HRQOL scores. Potential publication bias and small-
 
 
 
 
study effects of the clinically relevant HRQOL outcomes were analysed by visually 
inspecting the funnel plots instead of statistical testing, given the small number of included 
studies.
25
 
  
 
 
 
 
Results 
Included studies 
Among all 2853 titles, 9 articles published from 2010 to 2016 were eligible for qualitative 
analysis (Figure 1).
5-7, 15, 17, 26-29
 Main features of these studies are summarized in Table 1. In 
total, the 9 studies included 2164 patients, of whom 1161 (58.3%) underwent minimally 
invasive surgery and 903 (41.7%) underwent open surgery. The median number of patients 
per study was 114 (range 56-888). In three studies, only patients with oesophageal squamous 
cell carcinoma were included,
17, 28, 29
 while one study included only patients with 
adenocarcinoma.
26
 Five studies also included patients with cancer of the gastroesophageal 
junction,
5-7, 15, 27
 and two studies included patients with high-grade dysplasia.
7, 15
 The presence 
of medical comorbidities was not described in two of the studies,
15, 27
 whereas fitness 
evaluations with American Society of Anesthesiologists grades (or ASA grades) were 
available in four studies.
5, 6, 26, 29
 In the 7 studies that described the use of neoadjuvant therapy, 
595 (32.4%) of the 1836 patients received such treatment.
5, 6, 15, 17, 26, 27, 29
 The number of 
patients receiving postoperative chemo- or chemoradiotherapy was described in only one of 
the 9 studies.
26
 
 
The main open surgical procedure was the right-sided transthoracic (Ivor-Lewis) 
oesophagectomy. Less frequent procedures included McKeown modification in an undefined 
number of patients, as well as left thoracoabdominal and left transthoracic oesophagectomy. 
No patients undergoing transhiatal resections were included in the studies. Thus, all patients 
in the open surgery group underwent thoracotomy. There was variability in the anastomotic 
technique and location. Of patients with minimally invasive surgery, at least 249 underwent 
totally minimally invasive oesophagectomy in five studies.
5, 7, 15, 17, 26
 Five studies had a 
hybrid approach or included both totally minimally invasive and hybrid minimally invasive 
 
 
 
 
oesophagectomy in the treatment group (912 patients).
6, 15, 27-29
 One of the studies included a 
comparison between laparoscopy-thoracoscopy approach and hybrid minimally invasive 
procedures including laparotomy or thoracotomy.
15
 One study utilized hand video-assisted 
thoracoscopic surgery as the minimally invasive procedure.
28
 Taken together, all studies 
included a minimally invasive group of patients who underwent thoracoscopy and an open 
oesophagectomy group of who underwent thoracotomy. Details on patients and surgery are 
further described in Tables 2 and 3. 
 
The HRQOL outcomes were measured using both the EORTC QLQ-C30 and the QLQ-
OES18 questionnaires in eight studies.
5-7, 17, 26-29
 In one study, MFI-20 and activities of daily 
living questionnaires suggested decreased fatigue and increased proportion of independent 
patients after minimally invasive surgery compared to open surgery at 3 and 6 months.
15
 All 
studies using the EORTC questionnaires measured HRQOL at baseline and postoperatively. 
One of the studies reported one-week outcomes, three studies reported two-week outcomes, 
four studies reported four-week outcomes, and two studies reported six-week outcomes. 
Seven of the studies measured HRQOL outcomes at 3-months and six at 6-months after 
surgery. Four studies measured 12-month HRQOL outcomes and two studies also reported the 
24-month outcomes. Reporting on HRQOL outcomes was generally selective; only three 
articles reported all or almost all of the numerical values for the EORTC QLQ-C30 and QLQ-
OES18 questionnaire outcomes. Two studies did not present any numerical values, but instead 
provided graphs. Only one study used evidence-based cut-off values for interpreting the 
differences in the HRQOL scores.
6, 20, 21
 
 
General cancer-related symptoms (EORTC QLQ-C30) 
 
 
 
 
One study measuring fatigue with MFI-20 scale was excluded from the quantitative 
analysis.
15
 The study did not report general fatigue and the subscales were not compatible 
with fatigue scale in the EORTC questionnaire. The meta-analysis was conducted on 4-6 
week and 3-, 6- and 12-month extracted outcome data on global quality of life, physical 
function, fatigue, and pain from the 8 included studies. Due to the small number of studies 
reporting outcomes at time points less than 6 weeks postoperatively, outcomes at 4-6 weeks 
from 5 studies were combined and analysed. Clinical heterogeneity was found between the 
study populations, as there were differences between the sub-location and histology of the 
cancers, as well as the study design. The I
2 
statistic indicated high statistical heterogeneity 
(>50%) for all of the analyses, except the global quality of life at 4-6 weeks (I
2
=25%) and 12 
months (I
2
=9%), fatigue at 12 months (I
2
=0%) and pain at 4-6 weeks (I
2
=25%). However, the 
baseline values for the studied outcomes in each study were similar in the treatment groups, 
with no MSD greater than 5 points between surgery groups.  
 
The meta-analyses of these key HRQOL outcomes showed that minimally invasive surgery 
was followed by better outcomes at 4-6 weeks and 3 months compared to open surgery. The 
MSDs at 4-6 weeks were 16.1, 95% CI 13.9 to 18.3 for global quality of life, 26.9, 95% CI 
19.0 to 34.9 for physical function, -18.8, 95% CI -29.3 to -8.3 for fatigue and -29.0, 95% CI -
31.6 to -26.5 for pain. The 3 month outcomes were also better after minimally invasive 
oesophagectomy for global quality of life (MSD 11.6, 95% CI 3.8 to 19.4), physical function 
(MSD 11.9, 95% CI 3.9 to 19.8), fatigue (MSD -13.2, 95% CI -17.6 to -8.8), and pain (MSD -
15.9, 95% CI -20.5 to -11.2). After 3 months there were no clinically significant MSDs in 
HRQOL outcomes, except for physical function at 6 months in favor of minimally invasive 
surgery (MSD 11.8, 95% CI -0.4 to 24.0), but this difference was not statistically significant. 
The forest plots and pooled estimates for the four outcomes are shown at 4-6 weeks 
 
 
 
 
(Supplementary figure 1), 3 months (Figure 2), 6 months (Supplementary figure 2) and 12 
months (Supplementary figure 3). Figure 3 shows the pooled differences of these key 
outcomes at different time points with 95 CIs. Majority of the patients should experience 
better global HRQOL and less pain at 4-6 weeks and less fatigue and pain at 3 months after 
surgery, as reflected by the 95% prediction intervals (Suppl. Figure 4). 
 
The sensitivity analysis of the pooled results excluding the studies using some imputed data 
showed that the observed pooled clinically significant differences at 3 months remained. The 
sensitivity analysis omitting one study at a time showed that the omission of one of the 
studies
29
 made the 3-month difference of surgical method on global quality of life and 
physical function clinically less relevant, but the difference remained statistically significant 
(MSD 8.5, 95% CI 5.6 to 11.4 for global HRQOL and MSD 9.0, 95% CI 4.7 to 13.4 for 
physical function, at 3 months). Sensitivity analysis was also conducted excluding the studies 
with hybrid minimally invasive operations. Based on pooled results from two to four studies 
at each time point, totally minimally invasive surgery had clinically (MSD >10 points) and 
statistically significant superior outcomes compared to open surgery until 3 months, but not at 
6 months, similarly to the main analysis. At 12 months, the difference in global HRQOL was 
not clinically significant. Other key outcomes at 12 months could not be analysed as data was 
available from only one study.  
 
Two studies showed decreased dyspnoea symptoms at 4-6 weeks after surgery in favour of 
minimally invasive esophagectomy.
27, 29
 There were no differences in other function scales 
(role, emotional, cognitive, or social) or symptom scales and items (nausea and vomiting, 
insomnia, appetite loss, constipation, diarrhoea, or financial problems) between the groups. 
 
 
 
 
However, the lack of reporting and obtaining the numerical values for these outcomes 
prevented formal meta-analysis of these outcomes. 
 
Oesophageal cancer-related symptoms (QLQ-OES18) 
There were no clinically relevant differences between open and minimally invasive 
oesophagectomy for most of the QLQ-OES18 outcomes at any time points in any of the 
studies. Six of the eight studies did not report the numerical data for the outcomes for one or 
more items. Thus, unbiased meta-analysis of these outcomes could not be performed. One of 
the studies
7
 reported statistically significant, but not clinically relevant, less oesophageal pain 
at 3 months, and two studies reported clinically relevant less oesophageal pain at 6 weeks
5
 
and 12 months
5, 6
 after minimally invasive surgery compared to open surgery. Also, two 
studies
5, 7
 reported clinically relevant fewer speech problems at 6-12 weeks postoperatively 
after minimally invasive surgery compared to open oesophagectomy.  
 
  
 
 
 
 
Discussion 
The results indicate that minimally invasive surgery is on average followed by better 
postoperative outcomes regarding global quality of life, physical function, fatigue, and pain 
up to 3 months after surgery, but these differences fail to persist at 6 or 12 months 
postoperatively.  
 
Methodological advantages of this meta-analysis include the strict inclusion criteria, use of 
well-validated questionnaires in all of the included studies, and using a cut-off of 10 for 
MSDs to reduce bias from multiple testing. 
11, 12, 20, 21
 The affected components between the 
surgical approaches had the same direction of effect at 4-6 weeks and 3 months 
postoperatively in all studies, suggesting actual effect of the treatment. Additionally, 
sensitivity analyses by removing any single study, all studies with extracted data or all studies 
that had hybrid minimally invasive operations from the analysis did not have major effect on 
the conclusions. Biases in the individual studies might affect the observed pooled effect size. 
Visual inspection of the funnel plots revealed no evidence of major small-study effects or 
publication bias. The effect estimates for clinically significant outcomes in the largest study in 
the meta-analysis were larger than the average effect estimate.
29
 Thus, no adjustment using 
the trim and fill method could be reliably done, as suggested earlier. 
30, 31
  
 
The surgical techniques used were variable in both open and minimally invasive groups. All 
included studies had however a thoracotomy group and a thoracoscopy group. Patients 
undergoing open surgery had variable procedures, such as Ivor-lewis and left-sided 
transthoracic oesophagectomy.
17
 These operations might have different postoperative 
recovery profiles. Studies included in the 4-6 weeks outcome analysis were only from Eastern 
countries, and might not be generalizable for this time point. The results were similar at later 
 
 
 
 
time points with Western studies included. Selective reporting and the inability to obtain the 
missing data may cause information bias. A weakness was the inability to perform meta-
regression and adjust the HRQOL outcomes for confounding, such as neoadjuvant treatment, 
due to the small number of studies.
32
 Patients selected for minimally invasive surgery might 
also be healthier than those selected for open surgery.
7
 Preoperative comorbidities increase 
complications, as well as poor quality of life outcomes.
33, 34
 Similar in-study preoperative 
baseline HRQOL values between treatment groups should adjust for some of these 
differences.
35, 36
 The 95% prediction intervals were calculated to depict the heterogeneity of 
the studies. It seems that most patients have better global HRQOL and less fatigue at 3 
months or less pain up to 3 months after minimally invasive surgery compared to open 
surgery. Minimally invasive oesophagectomy might reduce complications, which could be the 
causal link in the improvements in HRQOL up to 3 months following surgery. 
 
This first meta-analysis comparing HRQOL outcomes between minimally invasive and open 
oesophagectomy identified benefits in four key outcomes following minimally invasive 
surgery in the short term. No differences remained with longer-term follow up. Most patients 
are likely to have some benefit from minimally invasive surgery in less pain up to 3 months 
and less fatigue and better global HRQOL at 3 months after surgery. There are some clinical 
and research implications that can be drawn from this meta-analysis. Although the 3-month 
perspective is relevant for patients and healthcare, the lack of differences in HRQOL after this 
period indicates that open surgery does not need to be abandoned, particularly if the surgeons 
are more comfortable with open surgery or in patients with contraindications to a minimally 
invasive approach. The learning curve can decrease the prognosis both in the short- and long 
term.
37
 This might be a particular concern for minimally invasive surgery, as shown in 
esophagectomy,
38-40
 as well as other procedures.
41-43
 Therefore, these results are not enough to 
 
 
 
 
generally recommend minimally invasive oesophagectomy. Patients want information about 
HRQOL outcomes after cancer surgery, but surgeons rarely inform the patients about such 
outcomes.
44
 Trauma related to thoracotomy is associated with postoperative pain.
45, 46
 Pain 
and decreased exertion caused by open surgery may severely influence respiratory function, 
pulmonary complication rate and postoperative HRQOL.
47-49
 The present study can help 
surgeons to inform patients about average effects on HRQOL when making treatment 
decisions. On-going and future studies and meta-analyses will increase information on the 
effect of minimally invasive surgery on postoperative HRQOL. Reporting all measured 
HRQOL outcomes and evaluating the relationship of complications and HRQOL outcomes is 
important in future studies.  
 
In conclusion, minimally invasive oesophagectomy with thoracoscopy seems to have superior 
HRQOL outcomes up to 3 months postoperatively compared to open surgery, but no 
differences remained after this initial postoperative period. These findings cannot be used for 
any changes in general recommendations on surgical approach, but can help inform the 
patient about average expected outcomes following oesophageal surgery. 
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Figure legends. 
Figure 1. Selection of the studies included in the systematic review and meta-analysis. 
Figure 2. Results of a meta-analysis of the health-related quality of life (HRQOL) outcomes at 
3 months after oesophagectomy for cancer. The mean differences in HRQOL scores are 
depicted in forest plots, with horizontal lines showing 95% confidence intervals (CI), for 
global HRQOL (A), physical function (B), fatigue (C) and pain (D). Higher scores in A and B 
indicate better function and higher scores in C and D indicate worse symptoms. Difference of 
more than 10 points is considered clinically relevant. IV, inverse variance; MIE, minimally 
invasive oesophagectomy; OE, open oesophagectomy.  
Figure 3. Pooled key health-related quality of life mean score differences (MSD)and 95% 
confidence intervals (CI) comparing minimally invasive versus open oesophagectomy at 
different time points. Negative MSDs were converted positive for clarity. Larger MSDs 
indicate better outcome after minimally invasive compared to open surgery. Dashed 
horizontal line indicates the threshold for clinical significance of each pooled mean 
difference. 
Supplementary figure 1. Results of a meta-analysis of the health-related quality of life 
(HRQOL) outcomes at 4-6 weeks after oesophagectomy for cancer. The mean differences in 
HRQOL scores are depicted in forest plots, with horizontal lines showing 95% confidence 
intervals (CI), for global HRQOL (A), physical function (B), fatigue (C) and pain (D). Higher 
scores in A and B indicate better function and higher scores in C and D indicate worse 
symptoms. Difference of more than 10 points is considered clinically relevant. Number of 
patients in Maas et al was obtained from Biere et al.
4
 IV, inverse variance; MIE, minimally 
invasive oesophagectomy; OE, open oesophagectomy 
Supplementary figure 2. Results of a meta-analysis of the health-related quality of life 
(HRQOL) outcomes at 6 months after oesophagectomy for cancer. The mean differences in 
HRQOL scores are depicted in forest plots, with horizontal lines showing 95% confidence 
intervals (CI), for global HRQOL (A), physical function (B), fatigue (C) and pain (D). Higher 
scores in A and B indicate better function and higher scores in C and D indicate worse 
symptoms. Difference of more than 10 points is considered clinically relevant. IV, inverse 
variance; MIE, minimally invasive oesophagectomy; OE, open oesophagectomy. 
Supplementary figure 3. Results of a meta-analysis of the health-related quality of life 
(HRQOL) outcomes at 12 months after oesophagectomy for cancer.  The mean differences in 
HRQOL scores are depicted in forest plots, with horizontal lines showing 95% confidence 
intervals (CI), for global HRQOL (A), physical function (B), fatigue (C) and pain (D). Higher 
scores in A and B indicate better function and higher scores in C and D indicate worse 
symptoms. Difference of more than 10 points is considered clinically relevant. IV, inverse 
variance; MIE, minimally invasive oesophagectomy; OE, open oesophagectomy. 
Supplementary figure 4. Pooled key health-related quality of life mean score differences 
(MSD) and 95% prediction intervals comparing minimally invasive versus open 
 
 
 
 
oesophagectomy for cancer. Negative MSDs were converted positive for clarity. Larger 
MSDs indicate better outcome after minimally invasive compared to open surgery. Dashed 
horizontal line indicates the threshold for clinical significance of each pooled mean 
difference.  
  
 
 
 
 
Tables 
Table 1. Characteristics, quality and HRQOL assessment of the 9 studies included in the 
systematic review. 
Reference 
Study 
interval Country Study mode 
Study 
quality 
Number 
of 
patients 
HRQOL 
questionnaires  
Questionnaire 
compliance 
Included 
time points 
in months 
               
Barbour, 
2016 
1998-
2011 Australia Cohort 8 487 
QLQ-C30, 
QLQ-OES18 >95% 3, 6, 12 
Hong, 
2013 
2009-
2012 China 
Randomized 
Cohort 8 114 
QLQ-C30, 
QLQ-OES18 93% 1, 3 
Maas, 
2015 
2009-
2011 
Italy, 
Netherla
nds, 
Spain RCT 8 115 
QLQ-C30, 
QLQ-OES18, 
SF-36 82% 1.5, 12 
Nafteux, 
2011 
2005-
2010 Belgium Cohort 7 166 
QLQ-C30, 
QLQ-OES18 86,5% 3, 6, 12 
Paramesw
aran, 2013 
2007-
2008 U.K. Cohort 7 86 
MFI-20, Brody-
lawton, Katz 
scale 77% 1.5, 3, 6 
Shen, 
2015 
2005-
2007 China 
Randomized 
cohort 7 62 
QLQ-C30, 
QLQ-OES18 95% 1, 3, 6 
Wang, 
2010 
2007-
2008 China Cohort 7 56 
QLQ-C30, 
QLQ-OES18 95% 1, 3, 6 
Wang, 
2015 
2004-
2013 China Cohort 7 888 
QLQ-C30, 
QLQ-OES18 100% 1, 3, 6, 12 
Zeng, 
2012 2010 China Cohort 8 90 
QLQ-C30, 
QLQ-OES18 90% 3, 6 
Abbreviations: QLQ-C30, European Organisation for Cancer Research and Treatment general quality of life questionnaire Core 
30; QLQ-OES18, European Organisation for Cancer Research and Treatment oesophageal cancer specific quality of life 
questionnaire Oesophageal 18;  RCT, Randomized clinical trial; SF-36, Short Form (36) Health Survey 36, MFI-20, Multi-
dimensional Fatigue Inventory 
 
  
 
 
 
 
Table 2. Surgery, gender age and neoadjuvant therapy distributions of the patients in the 
included studies  
References Number of patients 
Gender 
Male/Female Mean age 
Neoadjuvant 
therapy 
  Open HMIO TMIO Open MIO Open MIO Open MIO 
Barbour, 2016 110 377 0 98/12 316/61 64* 64* 56/110 202/377 
Hong, 2013 55 0 59 41/18 38/17 56 56 0/55 0/59 
Maas, 2015 56 0 59 46/10 43/16 62* 62* 56/56 59/59 
Nafteux, 2011 101 0 65 82/19 49/16 64 63 ND ND 
Parameswaran, 
2013 19 31 36 15/4 47/20 64* 
67, 
64*
a 
17/19 
27/31, 
23/36 
Shen, 2015 29 33 0 23/6 25/8 ND ND ND ND 
Wang, 2010 29 27 0 19/10 19/8 58 61 0/29 0/27 
Wang, 2015 444 63 381† 358/86 362/82 56* 56* 75/444 80/444 
Zeng, 2012 30, 30
b 
0 30 
19/11, 
20/10
b
  21/9 58, 63
b 
66 0/60 0/30 
†analysed as HMIO; *median; aTwo groups, HMIO, TMIO; bTwo groups, Ivor-Lewis, left transthoracic 
Abbreviations: MIO, minimally invasive oesophagectomy; HMIO, hybrid minimally invasive oesophagectomy; 
TMIO, totally minimally invasive oesophagectomy; ND, not described. 
 
 
 
 
 
Table 3. Tumour stage, operative time, rate of R0 resection margins and hospital stay in the 
included studies. 
References 
Tumour stage  
(HGD/0-I/II/III-IV) 
Mean operation 
time (min) 
R0 resection 
margins (%) 
Hospital stay in 
days (median) 
  Open MIO Open MIO Open MIO Open MIO 
Barbour, 2016 0/16/35/59 0/131/125/121 ND ND 82 91 15 13 
Hong, 2013 0/0/24/35 0/0/19/36 362 521 100 100 26 16 
Maas, 2015 0/11/22/19 0/14/26/15 299† 329† 84 92 14† 11† 
Nafteux, 2011 14/87/0/0 10/55/0/0 322 375 100 100 11 10 
Parameswaran, 
2013 
0/0/8/11 0/6/12/13, 
5/7/13/10
a 
330 360, 
390
a 
ND ND ND ND 
Shen, 2015 0/20/7/2 0/22/10/1 ND ND ND ND ND ND 
Wang, 2010 0/5/19/5 0/6/18/3 309 267 ND ND 4* 2* 
Wang, 2015 0/69/255/120 0/62/254/128 211 191 ND ND 12 11 
Zeng, 2012 
0/2/9/19, 
0/3/11/16
b 
0/0/13/17 287, 
143
b 
306 ND ND ND ND 
a 
two groups, hybrid minimally invasive surgery, totally minimally invasive surgery; 
b
two groups; Ivor-Lewis 
oesophagectomy, left transthoracic oesophagectomy; †data from Biere, 20124; *ICU stay. 
Abbreviations: HGD, High-grade dyplasia; MIO, minimally invasive oesophagectomy. 
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